Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Cash from Operations (2020 - 2025)

Journey Medical's Cash from Operations history spans 6 years, with the latest figure at 6284000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 382.43% year-over-year to 6284000.0, compared with a TTM value of 12441000.0 through Dec 2025, down 36.31%, and an annual FY2025 reading of 12441000.0, down 36.31% over the prior year.
  • Cash from Operations for Q4 2025 was 6284000.0 at Journey Medical, down from 2383000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 18747000.0 in Q3 2023, with the low at 16520000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 1602150.0, with a median of 2607500.0 recorded in 2025.
  • Year-over-year, Cash from Operations surged 357.44% in 2023 and then tumbled 425.0% in 2024.
  • Tracing DERM's Cash from Operations over 5 years: stood at 3206000.0 in 2021, then dropped by 19.65% to 3836000.0 in 2022, then plummeted by 330.66% to 16520000.0 in 2023, then surged by 113.47% to 2225000.0 in 2024, then crashed by 382.43% to 6284000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Cash from Operations are 6284000.0 (Q4 2025), 2383000.0 (Q3 2025), and 942000.0 (Q2 2025).